ML20041E420
| ML20041E420 | |
| Person / Time | |
|---|---|
| Site: | Waterford  |
| Issue date: | 03/08/1982 |
| From: | Goldman M CALIFORNIA, UNIV. OF, DAVIS, CA, NRC |
| To: | |
| Shared Package | |
| ML20041E418 | List: |
| References | |
| ISSUANCES-OL, NUDOCS 8203100499 | |
| Download: ML20041E420 (42) | |
Text
I
-&gf3'2-
~
UtlITED STATES OF AMERICA NUCLEAR REGULATORY COMMISSION BEFORE THE ATOMIC SAFETY AND LICENSING BOARD In the Matter of
)
LOUISIANA POWER AND LIGHT
)
Docket No. 50-382 OL COMPANY
)
(llaterford Steam Electric Station,
)
Unit 3)
)
NRC STAFF TESTIMONY OF DR. MARVIN GOLDf4AN REGARDING CONTENTION 8/9 Q.1.
Please state your name and occupation.
A.1.
fly name in Marvin Goldman.
I am a Professor of Radiobiology at the University of California at Davis, and am Director of its Laboratory for Energy-Related Health Research.
0.2.
Please describe briefly your experience in the field of radiation resea rch.
A.2.
I have over 30 years of experience in radiation research.
I have authored over 100 papers and reports on radiation-related topics.
I have consistently contributed to the radiation research missions and efforts of the National Academy o# Sciences, the National Council on Radiation Protection and Measurements, the United States Environrental Protection Agency, the U.S. Nuclear Reculatory Commission, the U.S. Department of Energy, and the National Institutes of Health.
My major area of expertise is in radiation effects on biologic systems, specifically from radionuclides and external radiation at low doses and rates. Recently, I participated in the preparation e203100499 820308 PDRADOCK05000g
~.
of the National Academy of Sciences' report on Safe Drinking Water in Health, in which I was the co-chairman of its section on Radio-act'ivity in Water.
Two years ago, I prepared a scientific projec-tion paper on cancer related radiation research for the Interagency Radiation Research Comittee which addressed a proposed Federal Radiation Research agenda.
Q.3.
Have you prepared a statement of your professional qualifications?
A.3.
Yes. A copy is attached to this testimony.
Q.4.
Please describe your experience and/or familiarity with the Waterford Steam Electric Station, Unit No. 3.
A.4.
I have reviewed the Final Environmental Statement related to the operation of Waterford Steam Electric Station, Unit No. 3 (NUREG-0779, September 1981),(1)
In addition, I testified before the Atonic Safety and Licensing Board in 1974 concerning the effects of low level radiation in connection with the Waterford Unit 3 construction permit application.
Q.5.
In what capacity are you testifying in this proceeding?
A.S.
My testimony in this proceeding represents my personal views alone, I
and is completely independent of and separate from any official positions or views of any of the agencies which support my research or of the University of California.
l l
s 0.6.
What is the purpose of this testimony?
A.6.
The purpose of this testinony is to respond to Contention 8/9
~
fil' d by the Joint Intervenors in this proceeding. Contention 8/9 e
reads as follows:
Applicant has failed to properly evaluate the cumulative and/or synergistic effects of low-level radiation with environmental pollutants, known or suspected to be carcinogens.
0.7.
Please summarize your views concerning the substance of Contention 8/9.
A.7.
I have conducted some of my own independent research concerning the topic of Contention 8/9, am familiar with the scientific literature in this area and have reviewed many of the references provided by the Joint Interverors in support of this contention.
On the basis of my experience and expertise, it is my opinion that a cumulative and/or synergistic interaction between low-level l
radiation and chemical carcinogens cannot be supported based on the evailable data.
I base this conclusion on ny personal knowl-edge of the consequences of low-level radiation, as well as on my l
understanding of various studies regarding the potential inter-l action of radiation in combination with a variety of chemicals.
l Q.8.
Please describe the cancer risks that result from low levels of irradiation.
A.8.
The data base is very extensive with regard to the consequences of l
l low levels of radiation exposure.
In this last decade alone there I
have been innumerable publications addressing this subject.
In my
+ - - - -
o opinion, two of the most significant of these are the 1977 Report by the United Nations Scientific Committee on the Effects of Atoinic Radiation (2) and the 1980 Report of the National Academy of Science Connittee on the Biolegical Effects of Ionizing Radiation (BEIR III).(3) The National Council on Radiation Protection and Measurements periodically issues reports addressing the problems of radiation.(4)
For purposes of this testinony I intend to draw upon the extensive documentation of the world's literature on radiation effects.
In this regard therefore, I would like to address radiation conse-quences directly in terms of cancer risks.
I will address problems relating to increases in lethal cancer risks associated with radia-tion exposures.
The ma,ior impact of the recent BEIR Report (3) was to indicate that the nodel or approach for calculations that it recommended and preferred translates to a person's cancer mortality risk value of approximately 1 in 10,000 for every rem absorbed in a lifetime.
This 1/10,000 is scientifically recorded as 1 x 10-4/ rem. Depend-ing on how one wishes to interpret the data, that value could range upwards or downwards by a factor of 2 or 3.
What is very significant and often overlooked, is that the exponent, 10-4, coin-cides quite closely with that published b..
the United Nations and that quoted most freouently by radiation scientists.
i
In terms of large populations, these risk values are sometimes expressed in terms of rates per million persons. This risk value wou'Id then correspond to about 100 additional cancer deaths per
~
million persons at risk following exposure to 1,000 mrem. This is a cancer death risk factor of about 1/10,000 persons per thousand millf rem over their lifetimes. We frequently use a dose concept of person-rem in population-dose calculations although some 1
considerable controversy is associated with this term. That is, 1,000 mrem = 1 rem, and I person receiving 1,000 mrem accounts for 1 person-rem. One could therefore summarize this assessnent by stating that the cancer risk could be described in terms of 5 per year per million person / rem or 100 cancer deaths per lifetime per nillion person-rem.
To assist placing this risk into perspective, it should be noted that natural background radiation in most of the United States is approxinately 100 mren/ year or 0.1 rem / year.(5) Thus a typical cohort of 1,000,000 people, each of whom received an annual i
natural background radiation dose of 0.1 rem / year, would account for dose commitment of 100,000 person / rem in a year.
If one uses the risk factor mentioned above, the inference is that about 0.5 additional cancer deaths per year occur for each million persons in the United States from background radiation sources. While there are considerable temporal and spatial variations in the available epidemiology data, it would appear that on the average, cancer death rates in the United States are approximately 1700 per i
year per million persons and, of these 1700, the calculation above would suggest less than one is "related to background radiation."
Q.9.
Please describe the radiation risks resulting from the proposed operation of Waterford Unit 3, and calculate the potential cancer mortality risk from Waterford Unit 3 radiologic dose commitments and from 10 CFR Part 50 Appendix I annual dose design objectives.
A.9.
Table 6.1 in the Final Environmental Statenent (p. 6-5) quotes the radiologic impact for the Waterford facility in terms of a population dose within an 80 km radius of 12 person rems / year.II)
The Waterford Final Environmental Statenent also estimates the 1980 populatien within 80 km to be 1.7 nillion and estimates it to grow at about 1% per year to a value of 2.1 million in the year 2,000.
The radiation cancer risk estimates provided by the BEIR III Report allow one to estimate the potential cancer impact of these radiation doses to the general population. This report estimates that a typical population night expect 167,300 cancer deaths per million persons on the average in the United States.
This rate, adjusted for a 1980 "Waterford" population of 1.7 million would yield a future cancer death expectancy of 285,600 for the popula-tion within the 80 km radius.
There is variability about this number fron region to region within the United States, but its nagnitude is quite constant.
By this, I mean the expectation would be some number between approximately 250,000 and 300,000.
l To this cancer death rate from all causes, one can add the additional cancer risk from the radiation releases during the
~
operation of the Waterford facility. Following the population of 1.7 nillion to " extinction", or until all of the people living at the time the plant commences operation have died, assumes that some age distribution of persons is present.
For purposes of this example, I will assume that the 12 person rems / year is a constant release rate and that it continues for 50 years, i.e., that the population has an average fifty year life expectancy, taking into account that the very young will live longer and that those who are older at the time the radiation doses start will not have such a life expectancy. Thus,12 x 50 or 600 person rem is the total Waterford related radiologic impact upon this population. The flational Academy Report quotes a cancer mortality rate expectation per million persons each exposed to 1,000 mren or 1 rem annually, that is per nillion person-rem per year, of 4,751.
The cancer risk for this total population continually receiving 12 person rem can then be calculated as the ratio of 12 person rem to 1,000,000 person rem.
That is to say 12/1,000,000 of 4,751, a value of approximately 0.06.
The calculation therefore adds 6/100 of one cancer from radiation originating at Waterford, to the 285,600 that would normally be expected in the lifetime of the population at risk. Other methods of calculacing the risk might alter this value by a factor of up to three, but the significant
information developed from this distillation of cancer risk estimation is that there would be less than one cancer death added to the population at risk. Our ability to predict normal cancer expectations of course is fraught with uncertainties with regard to the absolute value. The rates vary fron parish to parish and from year to year, but In general their magnitude is not, in my opinion, markedly altered. Adding 20% to the population size for the year 2,000 increases all of these numbers by roughly 1% per year and still the totality of the radiation risk in my opinion is less than one " death". The reason the cancer risk estimation from radiation is so small is that 12 person ren divided by 1.7 million persons averages to a 7 micro rem annual dose added to the 100 mrem of background radiation.
These same figures can be discussed in terns of individual cancer risks.
167,300 cancer deaths per million, or an individual cancer risk of approxinately 16.7%, is the individual lifetime cancer nortality risk from all causes.
We could then add background radiation at 0.1 ren for 70 years of average life expectancy or an additional seven rem of natural background radiation. Multiply that by 1 x 10-4, the individual cancer risk per rem, and one obtains a 7 x 10-4 cancer risk.
To these values, let us assume hypothetically that the Waterford plant operates at the EPA limit specified in 40 CFR Part 190, with an annual dose equivalent of 25 mrem per person to the whole body (which is above the NRC's 10 CFR Part 50 Appendix I objectives), and that this goes on for the
O lifetime of the individuals. Thus 0.025 ren/ year x 70 provides an estimated lifetime dose commitment of about 1.75 ren, which, when mul'tiplied by the cancer risk coefficient yields a value of about O.0002.
Taking some liberties of rounding off, I weuld then say that the radiologic contribution to an average person's cancer risk would increase the cancer risk probability from 16.730 to 16.731%. The way in which one calculates these numbers can very slightly, but the magnitude of these numbers is un' nely to vary.
Q.10. Please describe the theory which underlies the concept of cumulative effects and synergism, as it relates to radiation and chemical carcinogensis.
A.10. Itcis well known that chemicals can be carcinogens, and particularly certain organic chemicals are known to be potent carcinogenic agents.
For some time it has been common practice in cancer research to follow the pattern elaborated by Berenblum some 40 years ago, of assuming that cancer is a two-stage process and that is potentiated by agents which can be characterized either as initiators or promotors.(0) Some agents nay, under certain cir-cumstances, act as complete carcinogens in that, in the context of this discussion, they act both as initiator and promotor.
In many instances, radiation is considered to be a complete carcinogen, acting as both initiator and promotor. The question of cumulative effects, and specifically the potential for synergism, would intuitively inply that a potent initiator was absorbed by critical tissues at risk and then followed at the proper time by cn active
o promotor. One can also postulate, in this same context, that the reversal of application sequence or the variation in ouantity of both agents applied could produce a spectrum of responses from antagonism to lack of tunor appearance to additivity or to a multiplicative or synergistic effect.
There are data to' support all of these interactions.
Q.11. please review and analyze the relevant studies concerning the existence or non-existence of any cumulative and/or synergistic effect of radiation and chemical carcinogenesis.
A.11. In the laboratory, a promoting agent, a phorbol-ester, when combined with x-irradiation of certain cells in tissue culture, has produced an interaction which was evaluated to be synergistic I
in magnitude.
The quantity of radiation or chemical and the timing of the application of both was critical to the results.
However, under the most ideal of conditions, using relatively high radiation doses (25 rem or more) the maximun enhancement was a factor of about eight or nine. The mixture of the chemical carcinogen benzo (a) pyrene with x-irradiation in cell cultures was also shown to have an enhancing factor of about eight-fold.(8)
It 1
should be understood that cell transformation in tissue culture does not provide a quantitative prediction of what would occur in vivo.
Laboratory studies on animals are the source of much of our information regarding models for interactions between chemicals
and physical agents.
It is importent to recognize that in the literature, many of the apparently contradictory findings can be int'rpreted as the results of a competition between the potential e
cell-killing toxicity of gents in high doses and that of the initiating-promoting consequences of lower doses.
Simply stated, at high doses cell-killing prevents the cells at risk from subse-quently transforming, and thus the quantification of the effects of mixtures of radiation with chemicals can influence the outcome.
One example of the additivity of radiation and a chemical carcinogen was published by Shellabarger, in which methylcholanthrene and/or 400 R of total body x-f rrediation was tested for namary adenocarcinoma induction potential.
The interaction of the chemical and radiation in this instance produced an additive effect.I )
In a different study on hamsters, it was shown that an interaction betwen alpha emitting radionuclide polonium-210 and benzo (a) pyrene could cause an enhancenent which was interpreted to be synergistic with regard to the induction of experimental lung cancer.
Interestingly enough, the major magnitude of the effect was attributed to the potentiating effect of sodium chloride saline solution, which appeared in this instance to act as a f
potent promoter.(10) i l
The interaction of a carcinogen with radiation was also investigated by further influencing imnunologic and hormonal parr t.ers.EII) Urethane lung tumors were studied in two different ways, i.e., "(1) carcinogenic alteration in the cellular i
l
genetic material, and (2) sterilization of cell proliferative ability.
Ionizing radiation can be additive in lung tumor ind' ction if each is used at low levels." The so-called " low
~
u dose" was 6 treatments of 50 R each. More recently three different strains of rats were also tested with the urethane-irradiation systen.II2)
It was noted that "from the cumulative mortality curves for all three strains of rats tested, it would appear that the overall carcinoger.ic stimulus and life shortening effect of x-irradiation and urethane together was not greater than the sum of their separate effects at the dosage levels studied".
Plutoniun can be a potent carcinogen when deposited in tissue.
In conbination with asbestos or benzpyrene in rats an enhanced effect was noted.03)
" Asbestos acted in an additive manner with Pu0 239 2
in inducing mesotheliomas, the two agents combined having an effect equal to the sum of their efforts when administered sepa rately. A similar additive response was seen with BP and 239Pu0 in the induction of abdominal sarcomas".
7 Radiation from external sources or from deposited radionuclides in combination with carcinogenic chemicals usually produces an addi-tive effect, if subtoxic levels are used.
53 In most laboratory studies optimal or rather large doses of chemical carcinogens and/or radiation were used. The quantifi-cation of the data are sufficiently difficult as to make it
- I3 -
virtually impossible to extrapolate the consequences of these inter-actions down to " environmental" levels of exposure to either radia-tion and/or chemicals.
There have been many reports in which experimental alteration of the levels of hormones in biologic test systens have induced a potent interaction with application of carcinogenic agents.
Frequently this enhancement appears to be a decrease in the cancer latency time or appearance time more than an increase in the incidence; that is, the same number of cancers appear earlier.
The data on humans is difficult to interpret in view of the possi-ble confounding influences of many competing variables in the environment.
Unlike the sinple pure " single test" system available in the laboratory, multiple factors may be present in the environment. Despite this, I am unaware of any clear causal effect of environmental carcinogens having been shewn in the general population, with the exception of the overpowering influence of cigarette tobacco smoke on lung cancer risks.
In this regard, there is an extensive literature regarding the interaction between cigarette smoking and exposure to the uranium mine environment on occupational risks for miners: at the higher levels of calculated radiation exposure, miners who were cigarette smokers had about a five-fold excess lung cancer risk compared to non-smoking miners.II4)
~
l l
I l
Q.12. In light of these. studies and your own experience and expertise in this and related areas, please provide your conclusions concerning the' existence or non-existence of any cumulative and/or synergistic
~
effect of radiation and chemical carcinogenesis.
A.12. Because of the variable response relationships in terms of ouantity and tenporal treatment variations in laboratory experi-ments, it is impossible at this tine to develop a strong support for a generalized synergistic effect of putative carcinogenic agents with irradiation at exceedingly low levels, i.e., levels related to Appendix I objectives. As with laboratory and epidemiologic studies, except for the situation regarding cigarette smoking in uranium miners, it is my opinion that there l
is no evidence of a proven synergistic interaction between radiation and chemical carcinogens as it relates to low level exposures. Since the few quantitative studies that have provided optimized synergistic. effects have shown the magnitude of this number to be of the order of less than a factor of ten at doses of carcinogen measured at the mg/kg of body weight level, I do not consider cunulative or synergistic impact of low levels of radia-tion in the mrem range of fractions of background natural radiation to pose any demonstrable increase in cancer risk in combination with exceedingly low levels of potential chemical carcinogens.
I must stress that the only levels at which these interactions have been shown were following acute or fractionated exposures which bordered on what is commonly assumed to be close to the lethal radiation range, i.e., tens of rems rather than millirems.
In my opinion, the data do not presently exist to' alter my assess-ment of cancer risk estinates from radiation exposure on the po,u-lat' ion based on a synergism between chemicals and radiation.
There are no convincing data to suggest that there is a real synergistic effect of low level radiation exposures in combination with putative chemical carcinogens at exceedingly low (ambient) concentrations.
In addition, it is particularly important to note that these interactions have only been proven in the laboratory when both the chemical carcinogen and the radiation were acting upon the same organ. When each of the agents acts upon different crgans, no interaction, to my knowledge, has been demonstrated.
~.. ~
REFERENCES 1.
NUREG-0779,(1981), Final Environmental Statement related to the
~
operation of Waterford Stem Electric Station, Unit No. 3, Docket No.
50-382, U.S. Nuclear Rege!etery Comission, Washington, D.C.
2.
United Nations (1977), Sources and Effects of Ionizing Radiation.
("UNSCEAR-1977 Report") United Nations, New York.
3.
National Academy of Sciences (1980). The Effects on Populations of Exposure to Low Levels of Ionizing Radiation ("BEIR III Report").
National Academy of Sciences, Washington, D.C.
4.
NCRP Report No. 64 (1980).
Influence of Dose and its Distribution in Time on Dose-Response Relationships for low-LET Radiations.
National Council on Radiation Protection and Measurements, Washington, D.C.
5.
NCRP Report No. 45 (1975).
Natural Background Radiation in the United States. National Council on Radiation Protection and Measurements, Washington, D.C.
6.
Berenblum, I. (1941). The mechanism of carcinogenesis. A study of the significance of carcinogenic action and related phenomena. Cancer Research 1: 807-14.
7.
Kennedy, A. R., et al. (1978). Enhancement of x-ray transformation by 12-o-tetradecanoyl-phorbol-13-acetate in a cloned line of C3H mouse embryo cells. Cancer Res. 38: 439.43.
8.
DiPaoli, J. A., et al. (1976).
Kinetics of Syrian Hamster cellt during x-irradiation enhancement of transformation in vitro by chemical ca rci nogen. Rad. Res. 66: 310.25.
9.
Shellabarger, C. J. (1967). Effect of 3-methylcholanthrene and x-irradiation, given singly or combined, on rat marmiary carcinogenesis.
J. Nat'1. Cancer Inst. 38: 73-77.
10.
Little, J. B., et al. (1978).
Interactions between polonium-210 x-radiation, benzo (a) pyrene, and 0.9% Nacl solution instillations in the induction of experimental lung cancer. Cancer Res. 38:1929-35.
- 11. Cole, L. J. and Foley, W. A. (1969). Modification of urethane-lung tumor incidence by low x-radiation doses, cortisone, and transfusic1 of isogenic lymphocytes. Rad. Res. 39: 391-99.
- 12. Myers, D. K. (1976). Effects of x-radiation and urethane on survival and tumor induction in three strains of rats.
Rad. Res. 65: 292-303.
1
- 13. Sanders, C. L. (1973). Cocarcinogenesis of 239 u02 with chrysotile P
asbestos or benzpyrene in the rat abdominal cavity.
In Radionuclide Carcinogenesis, pp. 138-153, Sanders et al., Eds. U.TT Atomic Energy Comm., Washington, D.C.
- 14. Archer, V. E. (1980). Epidemiologic studies of lung disease among miners exposed to increased levels of radon daughters.
Ijl Health Implications of New Energy Technologies, pp.13-22.
Ron and Archer, Eds., Ann Arbor Science Publ., Inc., Ann Arbor, Mich.
5
/
I l
=
\\
STATEMEf1T OF PROFESSI0t1AL QUALIFICATIONS MARVIN GOLC."A" I am Director of the Laborator merly the Raillobiology Laboratory) y for Energy-Related Health Research (for-of the University of California at Davis.
I also hold faculty positions as Professor of Radiological Sciences in the School of Veterinary 11edicine and of Radiobiology in the Radiology Department of the School of Medicine, and am affiliated with the Division of Environmental Studies of the Davis Campus.
I have a bachelor's degree from Adelphi University (1949),
a master's degree in physiology from the University of Maryland (1951), and a Ph.D. degree from the University of Rochester School of Medicine and Dentistry, Deprtment of Radiation Biology and Biophysics (1957).
Over the past 30 years I have been engaged in radiation and bioenvironmental research.
I was a biologist with the National Institutes of Health, a physicist with the flew York Department of Hospitals, and I held a fellowship and scholar-ship at the University of Rochester during my graduate training and was later an assistant scientist in their radiation toxicology section.
In 1958, I came to the University of California where I assumed the responsibilities I have just described.
I am a member of the Radiation Research Society, the Health Physics Society, American Association for Cancer Research, the International Society for Experi-
-mental Hematology, the New York Academy of Sciences, the American Association for the Advancement of Science, and the Honorary Science Society, Sigma Xi.
I have been a member of the National Council of Radiation Protect; ion and am active in reveral of its committees.
I have been on advisory committees for the Food and Drug Administration's Bureau of Radiological Health, the National Academy of Science's Ad Hoc Committee on " Hot Particles" and a co-chairman of its Radioactivity Subcommittee of the Safe Drinking Water Committee.
I serve as advisor or a consultant to several state and federal agencies including the fluclear Regulatory Commission, the Environmental Protection Agency and the Defense Nuclear Agency.
I am chairman of DOE's biomedical working group which assists in evaluating the safety of radioactive thermoelectric generators on spacecraft.
I was a coinvestigator on an AEC-supported radioccology project which evaluated the transport and optake of fallout radiostrontium and radio-cesium vegatation and in animals.
I am principal investigator of a project funded by NASA to assess hyper-gravitational changes in bone.
I am senior editor of a book on the " Biomedical Implications of Radiostrontium Exposure" which was published in 1972 and which synthesized and summarized the status of our knowledge on radioactive strontium.
I was the recipient of the AEC's E. O. Lawrence Award for 1972, for contri-butions to the " understanding of the effects of bone-seeking radionuclides, in particular longterm strontium-90 exposure."
I have been the author or coauthor of over 100 scientific articles and technical reports relating to the biological effects of radiation and particularly to those from radionuclides such as are procuced by nuclear reactors.
I am new also involved in developing and directing a major research program on the health effects of fossil fuel combustion and conversion.
A resume and listing of publications is attached hereto.
MARVIN GOLDt1AN DL*REES IIELD AB Adelphi University 1949 (Biology)
MS University of Maryland 1951 (Zoology-Physiology)
PhD University of Rochester 1957 (Radiation Biology)
Department of Radiation Biology and Biophysics POSITIONS IIELD Director, Radiobiology Laboratory, University of California, Davis (1973-Prescnt)
Professor of Radiobiology, Department of Radiological Sciences, School of Veterinary Medicine, and Department o,f Radiology, School of Medicine, University of California, Davis (1973-Present)
Professor (Adjunct) of Radiobiology, Department of Physiology, School of Medicine, University of California, Davis (1969-1973)
Lecturer, Department of rhysiological Sciences, School of Veterinary Medicine, University of California, Davis (1962-Present)
Research Radiobiologist, Radiobiology Laboratory, University of California, Davis (1964-Present); Associate Radiobiologist (1958-1964); Associate Director for Science (1972-1973)
Biophysicist-Physiologist, Division of Biomedical and Environmental Research, United States Atomic Energy Commission (1972-1973)
Consultant, California Energy Resources Conservation and Development Commission (1976-Present)
Consultant, U. S. Nuclear Regulatory Commission (1975-Present)
Member, Radiation Safety Committee, University of California, Davis (1976-Present)
Chairman, Biomedical Working Group, Division of Nuclear Applications, Division of Biomedical and Environmental Research, United States Energy Research and Development Administration (1973-Present)
l'!arvin Goldman Page 2 Member, Cancer Research Coordinating Committee, University of California (1973-Present)
Co-principal Investigator, Nill /NCI, Tumor Biology Training Grant, University of California, Davis (1972-Present)
Member, Advisory Committee, Crocker Nuclear Laboratory, University of California, Davis (1971-Present)
Member, Ad floc Committee on flot Particles, U. S. National Academy of Sciences, National Research Council (1974-1977)
Member, Safe Drinking Water Committee, U. S. National Academy of Sciences, National Research Council (1976-1977)
Member, Environmental IIcalth and Safety Committee, University of California, Davis (197S-1976)
Principal Investigator, Studies on Canine Bone Density, NASA, (NAS2-6763),
University of California (1972-1973)
Consultant, General Electric Company (1971-1972) 89 Principal Investigator, Studies on Sr Toxicity in Mice, USPilS, University of California, Davis (1970-1971)
Collaborator, Orbital Flight Effects on Calcium Kinetics and Fracture Ilealing Repair, NASA, (NAS2-5057), University of California, Davis (1968-1971)
MEMBERSilIPS IN PROFESSIONAL SOCIETIES American Association for the Advancement of Sciences American Association for Cancer Research licalth Physics Society International Society for Experimental llematology National Council on Radiation Protection and Measurements Full member of Council and member of Committees 30 and 34 New York Academy of Sciences Radiation Resealch Society Sigma Xi Society for Experimental Biology and Medicine
tbrvin Goldman
- Page 3 RESEARCll INTERESTS Director, UCD Radiobiology Laboratory, responsible for program studying the effects of radiation on biologic systems, primarily the long-term effects of 90Sr and 226Ra; effects of fossil fuel effluents; biomedical models for risk assessment.
Radiation neoplasms and aging changes; tissue content of trace elements; thermoluminescent dosimetry; whole body counting and gamma ray spectrometry; radiation effects on cells.
Radionuclide metabolism, kinetics, and effects on bone and hematopoietic tissues.
Bioenvironmental effects of radiation; radiation ecology. Cancer diagnosis using nuclear medicine and biophysics techniques; biomedical engineering; comparative pathology.
AWARDS The E. O. Lawrence Memorial Award presented by the US Atomic Energy Commission, 1972.
PUBLICATIONS See attached list.
l
1 PUBLICATIONS Marvin Goldman PUBLISHED PAPERS 1.
1958 Goidman, M., S. R. Glasser, and L. W. Tuttle.
Extraembryonic vascular deterioration in irradiated chick embryo. Proceedings of the Society for Experimental Biology and Medicine 97:385-387.
2.
1959 Goldman, M., and L. W. Tuttle.
Radiation and hormone effects upon lymphocyte release from isoli.ted perfused dog spleens.
International Journal of Radiation Biology 4:403-413.
3.
1960 Andersen, A. C., and M. Goldman.
Outdoor kennel for dogs. Journal of the American Veterinary Medical Association 137:129-135.
4.
1961 Stover, Betsy J., M. Goldman, and A. C. Andersen.
Failure of a dog to discriminate between Sr-90 and Calcium given orally.
Nature 191:713-714.
5.
1962 Andersen, A. C., and M. Goldman.
Pathologic sequelae in Beagles following continuous feeding of Sr-90 at a toxic level. M Some Aspects of Internal Irradiation (T. F. Dougherty, et al., Eds.),
Pergamon Press, Oxford, pp. 319-328.
6.
1963 Andersen, A. C., M. Goldman, R. Della Rosa, and D. McKelvie.
Fallout hazards to man studied through life-span tests with Beagles.
California Agriculture 17(12):2-3.
7.
1963 Goldman, M., R. P. Anderson, E. Edgerley, Jr., and A. D. Ray.
The removal of Strontium-90 from organic waste. Health Physics 9:847-855.
8.
1965 Goldman, M., W. M. Longhurst, R. J. Della Rosa, N. F. Baker, and R.
D. Barnes. The comparative metabolism of Sr, Ca, and Cs in deer and sheep.
Health Physics 11:1415-1422.
9.
1965 Della Rosa, R. J., M. Goldman, A. C. Andersen, C. W. Mays, and B. J.
Stover.
Absorption and retention of ingested strontium and calcium in Beagles as a function of age.
Nature 205:197-198.
l 10.
1965 Goldman, M., and R. P. Anderson.
X-ray fluorescence determination of strontium in biologic materials by direct matrix-transmittance correction.
Analytic Chemistry 37:718-721.
11.
1966 Goldman, M., R. P. Anderson, J. P. Henry, and S. A. Peoples.
X-ray emission spectrographic determination of thallium in biologic materials. Journal of Agriculture Food Chemistry 14:367-369.
12.
1966 Longhurst, W. M., M. Goldman, and R. J. Della Rosa.
Comparison of the environmental and biological factors affecting the accumulation of strontium-90 and cesium-137 in deer and sheep. M Radioecological Concentration Processes (B. Aberg and F. P. Hungate, Eds.), Pergamon Press, Oxford, pp. 635-648.
2 13.
1967 Rosenblatt, L.
S., and M. Goldman.
The use of probit analysis to estimate dose effects on postirradiation leukocyte depressions.
(A Preliminary Report.) Health Physics 13:795-798.
14.
1967 Casey, H. W., D. R. Cordy, M. Goldman, and A. H. Smith.
Influence of chronic acceleration on the effects of whole-body irradiation in rats.
Aerospace Medicine 38:451-457.
15.
1967 Goldman, M., and R. J. Della Rosa.
Studies on the dynamics of strontium metabolism under condition of continual ingestion to maturity. M Strontium Metabolism (J. M. A. Lenihan, J. F. Loutit, and J. H. Martin, Eds.), Academic Press, London.
pp. 181-194.
16.
1967 Fuller, J., E. D. Beckman, M. Goldman, and L. K. Bustad. Selenium determination in human and swine tissues by X-ray emission spectrometry.
Ia Selenium in Biomedicine (O. H. Muth, J. E.
Oldfield, and P'-~H. Weswig, Eds.), Avi Publishing Co., Westport, Conn., pp. 119-124.
17.
1968 Goldman, M. and E. D. Beckman.
X-ray emission quantitation of trace elements in biomedical research.
I_n Developments in Applied Spectroscopy (W. K. Baier, A. J. Perkins, and E. L. Grove, Eds.),
Plenum Press, New York, 6:13-28.
18.
1968 H. G. Wolf, L. Siemon, A. Philbrick, M. Goldman, and L. K. Bustad.
Cytogenetic effects of X-irradiation and Sr-90 in Marmosa mitis.
Mammalian Chromosomes Newsletter 9:48.
19.
1968 Della Rosa, R. J., H. G. Wolf, and M. Goldman. Translocation of 90 r from maternal skeleton to progeny during gestation and S
lactation. h Proceedings of the First International Congress of Radiation Protection, Rome, Italy, September 5-10, 1966.
Pergamon Press, Oxford 1:201-204.
20.
1968 Della Rosa, R. J., M. Goldman, and L. K. Bustad.
Assessment of 90 r body burdens in vivo in relation to the metabolic time course S
following uniform skeletal contamination.
In Diagnosis and Treatment of Deposited Radionuclides (J. F. Park et aE, Eds.), Excerpta Medica, Amsterdam, pp. 152-163.
21.
1968 Goldman, M., and R. P. Anderson.
U. S. Patent No. 3,375,369. Matrix corrected X-ray fluorometric analysis method.
22.
1969 Dungworth, D. L., M. Goldman, and D. H. McKelvie.
Development of a form of myelogenous leukemia in Beagles continuously exposed to Strontium-90.
Experimental Hematology 16:54.
23.
1969 Tennant, B., M. Reina-Guerra, D. Harrold, and M. Goldman.
Influence
~
of microoraanisms on intestinal absorption:
oleic acid 131 1 and triolein 131 1 absorption by germfree and conventionalized rats.
Journal of Nutrition 97:65-69.
24.
1969 Dungworth, D. L., M. Goldman, J. W. Switzer, and D. H. McKelvie.
Development of a myeloproliferative disorder in Beagles continuously exposed to 90Sr.
Blood 34:610-632.
3 l
25.
1969 Goldman, M., R. J. Della Rosa, and D. H. McKelvie. Metabolic,
dosimetric, and pathologic consequences in the skeletons of Beagles 90 r.
In Delayed Effects of Bone Seeking Radionuclides (C. W.
fed S
Mays, Ed.),7niv. of Utah Press, pp. 61-77.
26.
1969 Bustad, L.
K., M. Goldman, L. S. Rosenblatt, D. H. McKelvie, and I.
I. Hertzendorf. Hematopoietic changes in Beagles fed 90Sr. -In Delayed Ef fects of Bone Seeking Radionuclides (C. W. Mays, Ed T, University of Utah Press, pp. 258-271.
27.
1969 Reina-Guerra, Mario, B. Tennant, D. Harrold, and M. Goldman. The absorption of fat by gennfree and conventionalized rats. Ge nn-Free Biology, Plenum Press, New York, pp. 297-300.
28.
1969 Goldman, M., D. L. Dungworth, M. S. Bulgin. L. S. Rosenblatt, W. P.
C. Richards, and L. K. Bustad.
Radiation-Induced Cancer.
International Atomic Energy Symposium, Athens.
pp. 345-360.
29.
1970 Andersen, A. C. and M. Goldman.
Growth and development.
In The Beagle as an Experimental Dog, ( A. C. Andersen, L. S. Good 7Eds.),
Iowa State University Press, Ames, Iowa, pp.43-105.
30.
1970 Goldman, M.
Skeletal mineralization.
In The Beagle as an Experimental Dog, ( A. C. Andersen, L. 5-Good, Eds.), Iowa State University Press, Ames, Iowa, pp. 216-225.
31.
1970 Goldman, M.
Removal of Strontium-90 from Organic Wastes.
In Water Quality and Management and Protection.
US Department of Interior, Water Resources Research Catalog, Vol. 5, pp.1-364.
32.
1970 West, J. E., F. D. Wilson, M. Goldman, and L. K. Bustad. Dose Rate Effects on Bone Marrow and Peripheral Blood after Simulated Solar Flare Irradiation in Beagles.
18th Annual Meeting of the Radiation Research Society, Dallas, Texas. pp. 6-7.
33.
1970 Goldman, M., R. J. Romer Williams, and M. S. Bulgin. Application of 226 a-induced bone lesions. Journal of Nuclear DF to image R
Medicine. 208-213.
34.
1970 Goldman, M., N. W. Hetherington, L. S. Rosenblatt, and L. K. Bustad.
The application of the logistic dose response surface in evaluation of tumor incidence following exposures to internal emitters.
Conference on Estimation of Low Level Radiation Effects in Human Populations, Argonne National Laboratory, 7-9 December 1970.
ANL
- 7811:7-8, 32.
Large Animal Studies.
35.
1971 Rosenblatt, L. S., N. Hetherington, M. Goldman, and L. K. Bustad.
Evaluation of tumor incidence following exposure to internal emitters -
by application of the logistic dose response surface. Health Physics 21(6):869-875.
4 36.
1971 Zanelli, G. D., P. J. Darley, and M. Goldman.
Marrow absorbed dose-rates in bones of Beagle dogs raised on diets containing Strontium-90.
French Society of Radiation Protection, 5th International Meeting, Grenoble, France,1-5 February 1971, pp.
381-400.
37.
1971 Bustad, L.
V,, C. W. Mays, M. Goldman, L. S. Rosenblatt, H. W.
Hetherington, W. J. Bair, R. O. McClellan, C. R. Richmond and R. E.
Rowland.
Evaluation of longterm effects of exposure to internally deposited radionuclides.
Fourth United Nations International Conference on the Peaceful Uses of Atomic Energy, Geneva, Switzerland, A/C0fiF-49/A-081,16 September 1971.
38.
1971 Celjan, J. R., A. B. Hellewell and M. Goldman.
The effect of calcium deficiency on healing of experimental fractures in the avian tarsus as determined by the fracture repair ratio.
Clinical Orthopaedics and Related Research 78:277-285.
39.
1971 Goldman, M., R. R. Pool, F. D. Wilson and J. E. West.
Nuclear medicine studies on the bone and marrow of Beagles. 21st Gaines Veterinary Symposium, Ames, Iowa, 20 October 1971, pp. 29-34.
40.
1972 Bustad, L. K., K. A. Stitzel, E. K. Haro, and M. Goldman. The choice of the Beagle for radiobiologic studies.
In Radiobiology of Plutonium, (B. J. Stover, W. S. S. Jee, EdE), The J. W. Press, University of Utah, Salt Lake City, Utah, pp. 203-211.
- 41. 1972 Goldman, M. and L. K. Bustad.
Proceedings synthesis. -In Biomedical Implications of Radiostrontium Exposure (M. Goldman, L. Y. Bustad, Eds.), USAEC Symposium Series 25 (CONF-710201), pp.1-17.
- 42. 1972 Della Rosa, R. J., M. Goldman, H. G. Wolf and L. S. Rosenblatt.
Application of canine metabolic data to man.
In Biomedical Implications of Radiostrontium Exposure, (M. GHdman, L. K. Bustad, Eds.), USAEC Symposium Series 25 (CONF-710201), pp. 52-67.
43.
1972 Goldman, M., R. J. Della Rosa and M. H. Homeni.
Radiation dose to Beagles from continuous 90 r exposure.
In Biomedical Implications S
of Radiostrontium Exposure, (M. Goldman, G K. Bustad, Eds.), USAEC Symposium Series 25 (CONF-710201), pp.103-113.
44.
1972 Spiers, F. W., G. D. Zanelli, P. J. Darley, Joan R. Whitwell and M.--~
Goldman.
Beta-particle dose rates in human and animal bone.
In Biomedical Implications of Radiostrontium Exposure, (M. Goldman-- L.
K. Bustad, Eds.), USAEC Symposium Series 25 (CONF-710201), pp.
130-148.
- 45. 1972 Wright, J. F., M. _Goldman and L. K. Bustad.
Age, strain and dose-rate effects of MSr in mice.
In Biomedical Implications of Radiostrontium Exposure, (M. C#'dman, L. K. Bustad, Eds.), USAEC Symposium Series 25 (CONF-71020.), pp.168-181.
46.
1972 Pool, R. R., R. J. Romer Williams and M. Goldman.
Strontium-90 toxicity in adult Beagles after continuous ingestion.
In Biomedical Implications of Radiostrontium Exposure, (M. Goldman, L. K. Bustad, Eds.), USAEC Symposium Series 25 (C0HF-710201), pp. 277-284.
5 47.
1972 Goldman, M. and A. C. Dixon. Dynamic scanning studies on canine osteosarcomas. Third International Conference on Medical Physics Including Medical Engineering, Goteborg, Sweden, 30 July-4 August.
48.
1972 Goldman, M., R. Pool, M. H. Momeni, F. D. Wilson, R. J. Romer Williams, C. Chrisp, L. S. Rosenblatt and L. K. Bustad.
Quantitation of 90Sr toxicity in dogs.
Second International Conference on Strontium tietabolism, Glasgow and Strontian, Scotland,16-19 August.
49.
1973 Goldman, M., L. S. Rosenblatt, N. W. Hetherington, and Miriam P.
Finkel.
Scaling dose, time, and incidence of radium-induced osteosarcomas of mice and dogs to man.
In Radionuclide Carcinogenesis, (C. L. Sanders, et al., Ids.), USAEC Symposium Series 29 (CONF-720505), pp. 347-357.
50.
1973 Pool, R. R., J. R. Williams, M. Goldman and L. Rosenblatt.90 r or Comparison of bgpe tumor sites in Beagles continually fed S
injected with 2 ara as a means of scaling risk to humans. M Radionuclide Carcinogenesis, (C. L. Sanders, et al., Eds.), USAEC Symposium Series 29 (CONF-720505), pp. 475-486.
51.
1973 Pool, R. R., R. J. Romer Williams and M. Goldman.
Induction of tumors involving bone in Beagles fed toxic levels of strontium-90.
American Journal of Roentgenology, Radium Therapy and Nuclear Medicine 118:900-908.
52.
1974 Hellowell, A. B., J. R. Beljan and M. Goldman.
Effect of chronic administration of a glucocorticoid (prednisolone) on the rate of healing of experimental osseous defects.
Clinical Orthopaedic and Related Research 100:349-355.
53.
1974 Goldman, M.
Comparison scales for radioactive and nonradioactive hazards. M Energy, The Environment, and Human Health (A. J. Fir.kel, Ed.), Publishing Sciences Group, Inc., Acton, Massachusetts, rp.
f 181-188.
l 54.
1974 Fisher, G. L., J. A. Schwind, T. D. Lee, and M. Goldman. A photon absorptiometer for in vivo and in vitro measurement of small animal bone density.
Biomedical Engineering 9:196-199, 213.
55.
1974 Momeni, M. H., L. Wordgn, and M. Goldman.
Dosimetry and facilities of UCD outdoor-indoor 00 o irradiation.
Health Physics 26:469-472.
C 56.
1974 Riggins, R. S., G. L. DeNardo, R. D' Ambrosia, and M. Goldman.
Assessment of circulation in the femoral head by lbf scintigraphy.
Journal of Nuclear Medicine 15:183-186.
57.
1975 Goldman, M. and S. A. Book. Radionuclide doses and their effects in
~
animals applied to human radiation protection criteria. M Third European Congress of the International Radiation Protection Association, May 13-16, 1975, Amsterdam, p. D-1.
58.
1975 Book, S. A. and M. Goldman.
Thyroidal radiof odine exposure of the fetus. Health Physics 29:874-877.
6 55.
1976 Bustad, L.
K., M. Goldman and L. S. Rosenblatt.
Inferences of radiation carcinogenesis revealed by selected studies in animals.
In Biology of Radiation Carcinogenesis (J. M. Yuhas, R. W. Tennant, ant J. O. Regan, Eds. ) Raven Press, New York, pp.13-29.
60.
1976 Goldman, M., F. D. Wilson, L. S. Rosenblatt, and S. A. Book.
Early radiation effects on bone and blood as " predictors" of osteosarcoma:
A late effect. -In Proceedings of the International Atomic Energy Agency Symposium on Biological and Environmental Effects of Low Level Radiation (Vol.1), Chicago, Illinois, 3-7 November 1975, I AEA, Vienna, pp. 335-342.
61.
1976 Rosenblatt, L.
S., M. Goldman, S. A. Book and M. H. Momeni.
Extrapolation of radiation-induced tumor incidence from animals to man.
In Proceedings of the International Atomic Energy Agency SymposTum on Biological and Environmental Effects of Low Level Radiation, Chicago, Illinois. 3-7 November 1975, IAEA, Vienna, pp.
237-242.
62.
1976 Goldman, M.
An overview of high LET radiation effects in cells. ---
In The Ef fects of Plutonium and Radium (W. S. S. Jee, Ed.), The J. W.
Press, Salt Lake City, Utah, pp. 751-766.
63.
1978 Goldman, M. and S. S. Yaniv.
Naturally occurring radioactivity in opthalmic glass.
In Radioactivity in Consumer Products (A. A.
Moghissi, P. Paras 7M. W. Carter, R. W. Barl.er, Eds.).
(NUREG/CP-0001) U. S. Nuclear Regulatory Commission. pp. 227-240, 1978.
64.
1979 Raabe, 0. G. and M. Goldman.
A predictive model of early mortality following acute inhalation of Pu02 aerosols.
Radiation Research 78: 264-277, 1979.
65.
1979 Goldman, M.
The scientific approach to radiation protection standards.
In Proceedings of the Atomic Industrial Forum Conference, EnvironmentaT Regulation: Looking Ahead, pp. 59-71, Monterey, California, June 1978.
66.
1979 Goldman, M.
Applicatir. of in vivo animal tests to human risk assessment.
In Proceedings of the Advisory Workshop on Carcinogenic Effects of Coat Conversion, Asilomar Conference Grounds, Pacific Grove, California, Sept.1978.
EPRI WS-78-110, Project WS-78-110, pp. 3 3-19,1979.
67.
1980 Hayes, T. L., J. B. Pawley, G. L. Fisher, and M. Goldman. Model for the exposure of individual lung cells to the foreign elements contained in fly ash.
Environmental Research 22: 499-509, 1980.
68.
1981 Raabe, O. G., S. A. Book, N. J. Parks, C. E. Chrisp, and M. Goldman.
226 a and 90 r toxicity in beagles - A status Lifetime studies of R
S report.
Radiation Research 86: 515-528, 1981.
69.
1981 Garsd, A., M. Goldman, and L. S. Rosenblatt. The prediction of skeletal mass in growing and adult beagles. Growth 45: 29-41, 1981.
a MARVIN GOLDMAN IN PRESS 1.
1982 Faulkin, L. F., D. J. Mitchell, D. D. Cardiff and M. Goldman.
Survival of mouse mammary gland transplants of normal hyperplastic and tumor tissues exposed to x-rays. Journal of the National Cancer Institute.
8 till1!TED DISTP,IBUTI0ft Government Reports 1.
1975 Goldman, M.
Late Somatic Effects.
In U. S. Nuclear Regulatory Commission (WASH-1400, NUREG-75/014)~~Kppendix VI G, pp.1-23 (The Rasmussen Report).
Annual Reports 1.
1968 Della Rosa, R. J., M. Goldman and L. W. Gilman.
Retention of Sr-90 body burdens acquired via gestation and nursing.
UCD 115, pp.19-20.
2.
1968 Goldman, M., and D. C. Van Dyke.
Bone-seeking radionuclide effects as deraonstrated by scintillation camera scanning. UCD 115, pp. 66-70.
3.
1968 Goldman, M., D. L. Dungworth, J. F. Wright, J. E. West, J. W. Switzer and H. Tesluk.
Myeloproliferative disorders in Sr-90 burdened Beagles.
UCD 115, pp. 72-74.
4.
1968 Goldman, M., K. K. Wolf, A. Kimi Klein and A. T. Foin.
Effects of X-irradiation on nucleic acid metabolism of Beagle lymphocytes in culture. UCD 115, pp. 75-77.
5.
1968 Huff, S. D., A. Kimi Klein, A. Foin and ti. Goldman.
Influence of biochemical parameters on metabolic responses of cells in culture.
UCD 115, pp. 78-82.
6.
1968 Goldman, M., E. Beckman, and J. M. Stone.
Some radio-and thermo-luminescent properties of tissues.
UCD 115, pp. 85-86.
7.
1968 Wolf, H. G., L. Siemon, A. L. Philbrick, C. D. Scott, M. Goldman and L. K. Bustad.
Cytogenetic effects of X-irradiation and Sr-90 in Marmosa mitis. UCD 115, pp.110-112.
8.
1968 Schwind, J., L. Gilman, and M. Goldman.
A magnetic tape output coupler system.
UCD 115, pp.116-117.
9.
1969 Della Resa, R. J. and M. Goldman.
Whole-body Sr-90 retention and distribution in trabecular and cortical bone of Beagles.
UCD 116, pp. 33-38.
10.
1969 Goldman, M., R. J. Romer Williams, and M. S. Bulgin.
F-18 scanning for visualTzation of Ra-226-induced bone lesions.
UCD 116, pp.
39-40.
11.
1969 Williams, R. J. Romer, R. J. Hanson, M. Goldman, and L. S.
Rosenblatt. Radiographic changes in skeletons of Beagles administered Sr-90 and Ra-226, UCD 116, pp. 41-44.
12.
1969 Goldman,11. and M. S. Bulgin.
Erythropoietic alterations in Beagles with Sr-90-induced myeloproliferative disorders.
UCD 116, pp. 73-77.
13.
1969 Goldman, M., D. L. Dungworth, it. S. Bulgin, L. S. Rosenblatt, W. P.
C. Richards, and L. K. Bustad.
Radiation-induced lethality frcm Sr-90 and Ra-226 administration to Beagles.
UCD 116, pp. 78-84.
9 14.
1969 Goldman, M., and E. Beckman.
Beta-emitting assay of radiostrontium isotope mixtures utilizing Cerenkov radiation.
UCD 116, pp.100-101.
15.
1969 Goldman, M., and r,. Shiomoto. Evaluation of ion exchange decontamination of Sr-90 from organic waste.
UCD 116, p. 129.
16.
1970 Della Rosa, R. J. and M. Goldman.
Whole-body Sr-90 retention and distribution in trabecular and cortical bone of Beagles.
UCD 117, pp. 41-45.
17.
1970 Della Rosa, R. J., it. Goldman and L. K. Bustad.
Sr-90 concentrations in soft tissues of Beagles. UCD 117, pp. 46-48.
18.
1970 Moment, M. H., R. J. Della Rosa, M. Goldman, and J. M. Stone.
Thermoluminescent dosimetry in Sr-90 labeled Beagle bones: A preliminary report. UCD 117, pp. 52-54.
19.
1970 Goldman, M. and J. M. Stone.
Luminescence in normal and neoplastic tissues.
UCD 117, pp. 55-56.
20.
1970 Goldman, M., R. R. Pool and R. Jean Williams.
Tumors involving bone in Beagles fed toxic levels of Sr-90:
Pathology and radiobiologic implications.
UCD 117, pp. 57-63.
21.
1970 Bulgin, M. S., F. D. Wilson, M. Shifrine and M. Goldman. Myeloproli-ferative disorders in Sr-90 fed Beagles.
UCD 117, pp. 64-72.
22.
1970 Goldman, M., L. S. Rosenblatt and L. K. Bustad.
Dose-rate induction of granulopoiesis with uniform Sr-90 skeletal labeling.
UCD 117, pp.
73-75.
23.
1971 Momeni, M. H., M. Goldman, and L. K. Bustad. Dosimetry of UCD 60 o C
radiation facilities.
UCD 118, pp. 25-33.
24.
1971 Della Rosa, R. J., M. Goldman, and L. S. Rosenblatt.
Application of canine metabolic data to man. UCD 118, pp. 68-70.
25.
1971 Momeni, M. H., M. Goldman, R. J. Della Rosa, C. D. Abrahams, and L.
90 r 90Y in humeri of Beagles.
L. Worden.
Dose distribution of S
UCD 118, pp. 71-78.
90 r toxicity in 26.
1971 Pool, R. R., R. J. R. Williams, and M. Goldman.
S adult Beagles.
UCD 118, pp.113-114.
226 a toxicity in 27.
1971 Williams, Jean R., R. R. Pool, and M. Goldman.
R adult Beagles:
Cumulative incidence of bone tumor and radiologic-pathologic correlation.
UCD 118, pp.115-117.
28.
1971 ficClatchy, C., L. S. Rosenblatt, L. K. Bustad, and M. Goldman.
Effects of Sr-89 ingestion by mice.
UCD 118, pp. 118-120.
- 29. 1971 Goldman, M.
Studies on radioactive strontium in animals and their relevance to man.
UCD 118, pp.121-130.
10
'30.
1971 Goldman, M., N. H. Hetherington, L. S. Rosenblatt, and L. K. Bustad.
Application of the logistic dose response surface in evaluating tumor incidence following exposures to internal emitters.
UCD 118, pp.
131-135.
31.
1972 Momeni, M. H., C. E. Chrisp, F. D. Wilson, M. Goldman, L. S.
continuous 60 o exposare, M. Shifrine, and H. G. Wolf.
Rosenblatt, D. Waterman Effects of C
on weanling and young adult Beagles: A preliminary pilot study.
UCD 119, pp. 44-49.
32.
1972 Davis, G. L., L. D. Carlson, and M. Goldman.
Calorimetry of Beagles.
UCD 119, p. 60.
33.
1972 Fisher, G. L., L. S. Rosenblatt, and M. Goldman. Trace elements in serum.
UCD 119, pp. 62-63, 34.
1972 Wilson, F. D., B. J. Bryant M. Goldman, and S. L. Munn. Altered hematopolesis in 90 r-and boRa-treated Beagle dogs. UCD 119, S
pp. 79-82.
35.
1972 Bryant, B. J., F. D. Wilson, and M. Goldman.
Bone marrow recovery in 220Ra-treated Beagle dogs: A provisional analysis.
UCD 119, pp.
83-85.
36.
1972 Goldman, M., J. W. Pharr, A. C. Dixon, and T. R. O'Brien. Dynamic scanning studies on canine osteosarcomas. UCD 119, pp. 95-96.
37.
19/2 Goldman, M., T. R. O'Brien, J. McRae, Y. Yano, D. Waterman, and J. W.
Pharr.
Application of a new bone scanning radiopharmaceutical in the study of bone tumors.
UCD 119, pp.97-100.
38.
1972 Momcni, M. H., M. Goldman and L. L. Worden.
Temporal and spatial local dosimetry of suSr udY in uniformly labeled Beagle humeri.
UCD 119, pp.120-123.
39.
1973 Goldman, M.
Comparison scales for radioactive and non-radioactive hazard s.
UCD 120, pp. 8-15.
1 40.
1973 Momeni, M. H., M. Goldman, H. G. Wolf, L. S. Rosenblatt, L. K.
l Bustad, V. T. Pietrzak, J. R. Uittmier, and N. Jow.
Average whole body skeletal dose rate and cumulative dose from 90 r 90Y body S
burden.
UCD 120, pp. 78-83.
41.
1973 Momeni, M.
H., M. Goldman, L. S. Rosenblatt, J. R. Wittmier, V. T.
Pietrzak, and N. Jow.
Calculation of dose rate and time-integrated dose by logistic and exponential functions.
UCD 120, pp. 90-95.
42.
1973 Fisher, G.
L., M. Goldman, E. A. Hinz, and T. D. Lee. Design, theory -
l and calibration of an tal densitometer.
UCD 120, pp.148-152.
43.
1974 Wilson, F. D., M. Goldman, C. E. Chrisp, L. S. Rosenblatt, C. J.
l McNeill, S. L. Munn, and M. Shifrine.
Hematologic effects: An j
overview.
UCD 121, pp. 40-58.
l L
11
' 44.
1974 Chrisp, C. E., R. R. Pool, M. Goldman, L. S. Rosenblatt, and R.
Schneider.
Cumulative mortality in radionuclide-treated beagles.
UCD 121, pp. 84-97.
45.
1975 Chrisp, C. E., R. R. Pool, M. Goldman, and L. S. Rosenblatt.
Cumulative mortality in radionuclide-treated beagles. UCD 122, pp.
'118-127.
46.
1975 Goldman, M. and L. S. Rosenblatt.
Some speculations on the role of radiation quality on " injury" and tumor risk for bone-seeking radionuclides.
UCD 122, pp.165-167.
47.
1976 Chrisp, C. E., R. D. Phemister, A. C. Andersen, L. S. Rosenblatt, and M. Goldman.
Pathology in a lifespan study of X-irradiated adult female beagles.
UCD 123, pp. 28-44.
48.
1976 Chrisp, C. E., R. R. Pool, W. Spangler, M. Goldman, L. Rosenblatt, and H. G. Wolf.
Cumulative mortality in radionuclide treated beagles.
UCD 123, pp.94-103.
60 o dog dosimetry.
UCD 124, pp.
49.
1977 Bradley, E. W. and M. Goldman.
C 84-87.
50.
1977 Chrisp, C. E., W. L. Spangler, R. R. Pool, M. Goldman, and L.
Rosenblatt.
Cumulative causes of death in radionuclide-treated beagles. UCD 124, pp.144-153.
51.
1977 Goldman, M.
Impacts of heavy metals and radioactivity from coal combustion.
UCD 124, pp. 192-194.
52.
1978-9 Raabe, 0. G., N. J. Parks, C. E. Chrisp, S. A. Book, and M. Goldman.
Comparison of effects in beagles from injected 226 a R
90 r.
UCD 125, pp. 142-148.
S and ingested 53.
1978-9 Raabe, 0. G. and M. Goldman.
A predictive model of pulmonary toxicity from inhaled plutonium oxide aerosols. UCD 125, pp.
193-199.
54.
1978-9 Book, S. A., C. E. Chrisp, M. Goldman, N. J. Parks, A. Philbrick, R. Pool, 0. G. Raabe, L. S. Rosenblatt, M. Shifrine, W. Spangler, R. G. White, and F. D. Wilson.
Comparative toxicity of 9uSr and 226 a:
Experimental design and current status. UCD 125, pp.
R 200-231.
55.
1980 Chrisp, C. E., G. L. Fisher, M. Goldman, A. Foin, A. Aotaki, H.
MacArthur, N. Thomas, and S. Wisecarver.
In vivo exposure of transplanted rat tracheas to fly ash.
UCD 126, pp. 64-65.
56.
1980 Stitzel, K., M. Shifrine, F. D. Wilson, S. Munn, A. K. Klein, E Goldman, H. Vriesendorp, N. Thomas, R. Graham, N. Taylor, E.
DeRock, W. Gee, L. Tow, and R. Kroll.
Overview of cobalt-60 external irradiation study, pp. 124-138.
57.
1980 Book, S., M. Goldman, N. J. Park s, 0. G. Raabe, L. S. Rosenblatt, and W. L. Spangler.
The toxicity of strontium-90 and radium-226:
experimental design and current status, pp. 252-292.
12 Abstracts 1.
1955 Goldman, M., S. R. Glasser, and L. W. Tuttle. Vascular changes in the irradiated chick embryo.
II.
Extra-embryonic vascular de'terioration.
(Abstr.) Radiation Research 3:228.
2.
1958 Goldman, M. and L. W. Tuttle. Hormone-induced lymphocyte release from isolated perfused dog spleen.
(Abstr.)RadiationResearch 9:120.
3.
1958 Tuttle, L. W., R. C. Baxter, and M. Goldman.
Effects of imbibed 90 r in rats.
(Abstr.) Radiation Research 9:195.
S 4.
1961 Goldman, M., A. C. Andersen, C. W. tiays, and Betsy J. Stover.
Studies on the continual feeding of 9uSr to the Beagle.
(Abstr.)
Radiation Research 14:469-470.
5.
1961 Della Rosa, R. J., M. Goldman, and C. U. Mays.
The retention of ingested strontium and calcium in Beagles as a function of age.
(Abstr.) Radiation Research 14:460-461.
6.
1962 Della Rosa, R. J., M. Goldman, and A. C. Andersen.
Discrimination 90 r.
against strontium in growing Beagles continually ingesting S
(Abstr.) Radiation Research 16:582.
7.
1962 Goldman, M., R. J. Della Rosa, and A. C. Andersen.
The uptake of 90 r by the growing Beagle.
(Abstr.) Proceedings continuously fed S
of the Second International Congress on Radiation Research, p.132.
8.
1963 Goldman, M.,'L. G. Young, and R. S. Edmonds. Whole body counting of bremsstrahlung from growing Beagles continually fed Sr-90.
(Abstr.)
Health Physics 9:874.
9.
1964 Goldman. M., L. Young, and T. J. Powell.
Radiation dosimetry of growing Beagle skeletons uniformly labeled with strontium-90.
(Abstr.) Ninth Annual Meeting of the Health Physics Society, 10:596.
10.
1964 Goldman, M., and R. J. Della Rosa.
Relationship of age to the retention kinetics of orally administered Ca-47 and Sr-85 in Beagles (Abstr.)RadiationResearch 22:190-191.
11.
1965 Goldman, M., T. J. Powell, and L. G. Young.
Retention of Sr-90 by the uniformly labeled Beagle.
(Abstr.) Radiation Research 25:192.
12.
1965 Powell, T. J. and M. Goldman.
A computational model for strontium-90 dosimetry in the chronically exposed Beagle.
(Abstr.) Health Physics -
11:816.
13.
1967 Bustad, L. K., M. Goldman, L. S. Rosenblatt, and A. C. Andersen.
Dosc-effect evaluation of chronic Sr-90 marrow irradiation on peripheral leukocytes of Beagles.
(Abstr.) Radiation Research 31:597.
13 14.
1967 Goldman, M., K. K. Wolf, A. K. Klein, and B. F. Nehman.
Radiosensi-tivity of cultured Beagle lymphocytes.
(Abstr.)RadiationResearch 31:598.
226 a dose 15.
1967 Rosenblatt, L. S., and M. Goldman.
Estimation of R
effects on leukocyte depressions in the Beagle.
(Abstr.) Radiation Research 31:597.
16.
1968 Goldman, M., K. K. Wol f, and A. K. Klein.
Effects of X-irradiation on nucleic acid metabolism of Beagle lymphocytes in culture.
(Abstr.) Radiation Research 35:504.
90 r irradiation on 17.
1968 McKelvie, D. H. and M. Goldman.
Effects of S
cortical bone following uniform labeling of Beagles.
(Abstr.)
Radiation Research 35:518.
18.
1969 Goldman, M., M. Bulgin, I. I. Hertzendorf.
Erythropoietic alterations in Beagles with Sr-90-induced myeloproliferative disorders.
(Abstr.) Radiation Research 39(2).
19.
1970 Della Rosa, R. J., M. Goldman, and L. K. Bustad.
90Sr concentra-tions in plasma and sof t tissues of beagles during and after continual ingestion.
Health Physics 19:338-9, 1970.
15th Annual Meeting of the Health Physics Society.
20.
1971 Goldman, M., N. W. Hetherington, L. S. Rosenblatt, and L. K. Bustad.
Application of the logistic curve to analyze radiation dose rate effects.
(Abstr.) Radiation Research 47:305.
21.
1972 Momengd M. H., M. Goldman, and L. Worae6.
Local dosimetry of 90 r-Y in the humeri of Beagles following uniform labeling.
S 20th Annual Meeting of the Radiation Research Society, Portland, Oregon.
(Abstr.) Radiation Research 51:54-55.
22.
1972 Goldman, M.
Long-term effects of internally deposited radionuclides.
American Nuclear Society Annual Meeting, Las Vegas, Nevada.
23.
1974 Goldman, M. and S. A. Book. A radiobiologist's view of light-water reactor effluents.
American Nuclear Society Transactions 18:391-392.
24.
1974 Momeni. M. H., M. Goldman, T. Countis, and L. Worden.
Estimation of effective gamma energy by differential responses of TLD-100 and TLD-200 dosimeters.
Fifth International Congress of Radiation Research, Seattle, Washington, July,1974.
25.
1974 Homeni, M. H., R. J. Romer Williams, L. S. Rosenblatt, and M.
Gol dma n.
Quantitative measurement of changes in 226 a-andT r-R S
vuY-labeled humeri:
A comparative study.
Fifth International Congress of Radiation Research, Seattle, Washington, July,1974.
26.
1974 Wilson, F. D., M. Goldman, S. L. Munn, C. J. McNeill and L. O'Grady.
The simultaneous determination of in vivo radiation survival characteristics for two clonogenic populations of bone marrow cells using methylcellulose culture systems.
Fifth International Congress of Radiation Research, Seattle, Washington, July, 1974.
14 o
27.
1975 Goldman, M., and F. D. Wil son. Chronic irradiation effects on hematopoiesis in beagles: Mechanisms of radiation-induced neut ropenia.
Fourth Annual Meeting of the International Society for Experimental Hematology, Trogir, Yugoslavia, September,1975.
28.
1976 Chrisp, C. E., R. D. Phemister, A. C. Andersen, L. S. Rosenblatt, and M. Goldman. Pathology in lifespan study of X-irradiated female beagles.
Twenty-fourth Annual Meeting of the Radiation Research Society, San Francisco, California, June 27-July 2,1976.
29.
1976 Wilson, F.
D., K. Stitzel, M. Goldman, K. Klein, R. Graham, and E.
Bradley.
Quaatitative response of bone marrow colony-forming units in culture (CFU-C and PFU-C) in weanling beagles exposed to whole body gamma-radiation. Twenty-fourth Annual Meeting of the Radiation Research Society, San Francisco, California, June 27-July 2,1976.
30.
1977 Goldman, M. and O. G. Raabe. An estimate of early mortality and morbidity following acute inhalation of plutonium.
American Nuclear Society 1977 Winter Meeting, San Francisco, California, November, 1977.
31.
1977 Goldman, M. and S. S. Yaniv.
Naturally occurring radioactivity in opthalmic glass. Symposium on Public Health Aspects of Radioactivity in Consumer Products, Atlanta, GA, February 1977.
32.
1978 Raabe, O. G. and M. Goldman. Estimates of mortality from inhalation 238 u0. Twenty-third of large quantities of WPu02 and P 2 Annual Meeting of the Health Physics Society, Minneapolis, Minnesota, June.
33.
1978 Bradley, E. W., M. Goldman, and O. G. Raabe. Energy determination of the scattered radiation outside the Radiobiology Laboratory, U.C.D.
60Co Outdoor Exposure Facility. May 1978 Industrial Hygiene Conference.
34.
1981 Book, S. A., W. L. Spangler, L. A. Swartz, and M. Goldman. Effects of lifetime ingestion of 90Sr in beagle dogs. Radiation Research 87: 445-446.
15 Oral Presentations 90 r retention and 1.
1970 Della Rosa, R. J., and M. Goldman.
Whole-body S
distribution in trabecular and cortical bone of Beagles. Second International Congress of the International Radiation Protection Association, Brighton, England, May 3-8.
2.
1970 Goldman, M., L. S. Rosenblatt, R. J. Della Rosa and L. K. Bustad.
The consequences of continual early-life exposure of Beagles to strontium-90.
4th International Congress of Radiation Research, Evian, France, June 29 - July 4.
3.
1970 Goldman, M.
Radiation hazanis of bone-seeking radionuclides.
Israel Atomic Energy Commission, Soreq lluclear Center, Yavne, Israel, July 14.
(Invitedlecture) 4.
1970 Bustad, L.
K., K. A. Stitzel, E. rs. Haro and M. Goldman.
The choice of the Beagle for radiobiologic studies.
Proceedings of the University of Utah Symposium, Plutonium as an Environmental Hazard, Salt Lake City, UT, October 8.
5.
1970 Goldman, M., H. W. Hetherington, L. S. Rosenblatt and L. K. Bustad.
Application of the logistic dose response surface in evaluation of tumor incidence following exposures to internal emitters.
Conference on Estimation of Lou Level Radiation Effects in Human Populations, Argonne flational Laboratory, Argonne, IL, December 7-9.
6.
1971 Zanelli, G. D., P. J. Darley and M. Goldman. Marrow absorbed dose 90 r.
rates in bones of Beagle dogs raised on diets containing S
Fifth International Congress, French Radioprotection Society, Grenoble, France, February 1-5.
7.
1971 _G_oldman, M.
Biomedical implications of radiostrontium exposure.
Co-chaiman and Editor.
AEC Symposium, UC Davis, Davis, CA, February 22-24.
l 8.
1971 Della Rosa, R. J., M. Goldman, H. G. Wolf, and L. S. Rosenblatt.
l Application of canine metabolic data to man.
AEC Symposium, i
Biomedical Implications of Radiostrontium Exposure, UC Davis, Davis, CA, February 22-24.
9.
1971 Goldman, M., R. J. Della Rosa and M. H. Momeni. Radiation dose to Beagles consequent to continuous 90Sr exposure. AEC Symposium, Biomedical Implications of Radiostrontium Exposure, UC Davis, Davis, CA, February 22-24.
90 r toxicity in 10.
1971 Pool, R. R., R. J. Romer tiilliams and M. Goldman.
S adult Beagles. AEC Symposium, Biomedical Implications of Radiostrontium Exposure, UC Davis, Davis, CA, February 22-24.
i 11.
1971 Spiers, F.11., G. D. Zanelli, P. J. Darley, J. R. Ilhitwell and M.
Goldman.
Beta particle dose rates in human and animal bone. AEC l
Symposium, Biomedical Implications of Radiostrontium Exposure, UC Davis, Davis, CA, February 22-24.
16 o,
12.
1971 Goldman, M.
Radiation and cancer.
Americua Cancer So::iety, Auburn, CA, April 16. (Invited lecture) 13.
1971 Goldman, M.
Utility of data from mammals for setting human pr.otection standards.
19th Annual Radiation Research Society Meeting, Boston, MA, May 10. (Invited Lecture) 14.
1971 Goldman, M., fl. W. Hetherington, L. S. P.osenblatt, and L. K. Bustad.
Application of the logistic curve to analyze radiation dose-rate effects.
19th Annual Radiation Research Society Meeting, Boston, MA, May 12.
15.
1971 Gol dman,11.
Studies on radioactive strontium in animals and their relevance to man.
Testimony at hearings for the siting of nuclear power reactors: Morris, IL, 9 December 1970 (Dresden); Port Clinton, OH, 9 February 1971 (Davis-Besse) Centerreach, fly, May 17 (Shoreham).
16.
1971 Goldman, M.
Radionuclide kinetics in physiologic research. Graduate seminar in physiology, Sacramento State College, Sacramento, CA, May 24.
17.
1971 Goldman, M.
Role of animal experimental data in setting human radiation protection guidelines.
UC Lawrence Radiation Laboratory, Livermore, CA, June 7.
(Invited lecture) 18.
1971 Goldman, M.
fluclear medicine studies on the bone and marrow of Beagles.
21st Gaines Veterinary Symposium, Ames, IA, October 20.
(Invited lecture) 19.
1971 Goldman, M.
Evaluation of radionuclide emission levels from the midwest f uel reprocessing plant.
Expert testimony at public hearings before the Illinois Pollution Control Board, Morris, IL, flovember 22-23.
20.
1971 Goldman, M.
fluclear medicine applications to radiation bio-effects studies. Armed Forces Radiobiology Research Institute, Bethesda, MD, December 15.
(Invited lecture) 21.
1972 Goldman, M.
Some aspects of nutrition in the nuclear age.
Seminar at UC Davis, Davis, CA, January 10.
22.
1972 Goldman, M.
fluclear medicine related research at the Radiobiology Laboratory, UC Davis, Sierra Valley Chapter of Society for fluclear Medicine, Davis, CA, January 15.
23.
1972 Goldman, M.
The applicability of long-term animal studies for human radiation protection standards.
Environmental Protection Agency, Twinbrook Research Laboratory, Rockville,110, January 31.
24.
1972 Goldman, M.
!!uclear medical applications to cancer assessment in experimental animals.
UC Los Alamos Scientific Laboratory, Los Alamos, fiM, February 10.
17 25.
1972 Goldman, M.
Radiation risk.
Seminar at UC Davis, Davis, CA, February 23.
26.
1972 Goldman, M. and L. S. Rosenblatt.
Evaluation of tumor incidence following exposure to internal emitters.
UC Donner Laboratory, Berkeley, CA, March 6.
27.
1972 Goldman, M.
Radiation in our society: fact and fancy.
Society of Physics Students and American Association of Physics Teachers Meeting, Sacramento State College, Sacramento, April 21.
(Invitedlecture) 28.
1972 Goldman, M.
fluclear medicine studies on the bone and marrow of Beagles.
Seminar at UC Davis, Davis, CA, May 2.
29.
1972 Goldman, M.
Studies on radioactive strontium in animals and their relevance to man.
Expert testimony at hearings on Effluente from Light Water-cooled fluclear Power Reactors, US Atomic Energy Commission, Bethesda, MD, flay 4.
30.
1972 Goldman, M., M. P. Finkel, L. S. Rosenblatt and it. W. Hetherington.
Scaling of dose time and incidence of radium-induced osteosarcomas in mice and dogs to man.
Hanford Biology Symposium, Richland, WA, May 12.
31.
1972 Goldman, M.
Experimental studies with internally deposited radionuclides.
Annual Meeting of the fiorth American Late Effects Group, Portland, OR, May 14.
90 r-32.
1972 Momeni, M. H., M. Goldman and L. Worden.
Local dosimetry of S
90Y in the humeri of Deagles following uniform labeling.
20th Annual Meeting of the Radiation Research Society, Portland, OR, May 16.
33.
1972 Goldman, M.
Radiation in our society:
fact and fancy. The Rotary Club of Davis, Davis, CA, June 5.
(Invited lecture) 34.
1972 Goldman, M.
Long-term effects of internally deposited radionuclides.
18th Annual Meeting of the American fluclear Society, Las Vegas, flV, June 19.
35.
1972 Goldman, M.
Expert testimony at US Atomic Energy Commission hearings, Joseph M. Farley fiuclear Plant, Dothan, AL, July 7-11.
36.
1972 Goldman, M. and A. C. Dixon.
Dynamic scanning studies on canine osteosarcomas.
The Third International Conference on Medical Physics, Including Medical Engineering, Goteborg, Sweden, August 3.
37.
1972 Goldman, M., R. Pool, M. H. Momeni, F. D. Wilson, R. J. Romer C. Chrisp, L. S. Rosenblatt, and L. K. Bustad.
Quantita-Williams $0 r toxicity in dogs.
tion of S
Second International Conference on Strontium Metabolism, Glascow and Strontian, Scotland, August 16.
18 38.
1973 Goldman, fi.
The utility of animal experimentation in estimating risks in man.
Seminar at Argonne flational Laboratory, Argonne, IL, liarch 29.
39.
1973 Goldman, M.
Comparison scales for radioactive and non-radioactive hazards.
American Medical Association's Congress on Environmental Health, Chicago, IL, April 29-30.
40.
1973 Goldman, M.
Facts and fancy about radiation carcinogenesis.
Seminar, Tumor Biology Group, UC Davis, Davis, CA, October 26.
41.
1974 Goldman,fl.
Expert testimony at US Atomic Energy Commission hearings, Beaver Valley Stations 1 and 2, Pittsburgh, PA, January 14-16.
42.
1974 Goldman, M.
A contemporary view on biologic effects of internal emitters.
Seminar, Laboratory of fluclear Medicine and Radiation Biology, UCLA, Los Angeles, CA, February 5.
43.
1974 Goldman, M.
Expert testimony at US Atomic Energy Commission hearings, Waterford Steam Generating Plant, 3, tiew Orleans, LA, February 19.
44.
1974 Goldman, M.
Some facts and fancies about long-term cor. sequences of nuclear energy related radiation on man and his environment.
Aerojet General Society Chapter of Sigma Xi, Sacramento, CA, May 16.
45.
1974 Goldman, M.
Some unusual aspects of nuclear medicine.
Sierra Valley Huclear Medicine Association Conference, Sacramento, CA, May 18.
46.
1974 Goldman, M.
Assessment of radionuclide body burden.
Nuclear Medicine Group, University of California, Davis, CA, August 6.
47.
1974 Goldman, M.
Risk assessments from internally deposited radionuclides.
Statistical Laboratory, University of California, Berkeley, CA, August 20.
48.
1974 Goldman, M.
Forum on nuclear energy assessment.
Channel 6 Educational Television, Sacramento, CA, September.
49.
1974 Coldman, M.
Energy sources and environment. Davis Audubon Society, Davis, CA, October 16.
50.
1974 Goldman, M.
Expert testimony at US Environmental Protection Agency Plutonium Hearings, Washington, D.
C., December 9-10.
51.
1975 Goldman, M.
Relative health effects.
Symposium on Understanding fiational Energy Production and Policy, University of California, Davis, CA, fiarch 1.
52.
1975 Goldman, ft.
Expert testimony at US Huclear Regulatory Commission hearings, Callaway Plants Units 1 and 2, St. Louis, M0, April 10.
19 e
53.
1975 Goldman, M.
Inferences on radiation carcinogenesis revealed by selected studies in animals.
Symposium on the Biology of Radiation Carcinogenesis, Gatlinburg, Til, April 7-10.
54.
1975 Gol dma n, M.
Biomedical aspects of nuclear energy generation.
State Department of Public Health, Sacramento, CA, October.
55.
1976 Goldman, M.
fluclear Energy (Panel).
American Institute of Metallurgical Engineers, Palo Alto, CA, February 18.
56.
1976 Goldman, M.
Biological effects of radiation.
American Institute of Biological Sciences, visiting scientist to California State University, Stanislaus - February 27.
Solano Comunity College - March 13.
Fresno State College - March 24.
Diablo Comunity College - May 18.
57.
1976 Goldman, M.
Radiation risks.
California Academy of !!edicine, Palm Springs, CA, March 11.
58.
1976 Goldman, M.
Radiation risk assessment.
Sandia Laboratories, Albuquerque, f4M, March 16.
59.
1976 Goldman, M.
Health aspects of nuclear fuel power generation.
Palm Springs Academy of Medicine, Palm Springs, CA, April 5.
60.
1976 Goldman, M.
Energy and the fluclear Initiative (Panel).
California Science Teachers Association, Fresno, CA, May 8.
61.
1976 Goldman, M.
?!uclear Initiative (Panel).
Congregation SherIth Israel, San Francisco, CA, May 25.
62.
1976 Goldman, M.
Radiation risks.
florthern California State Dental Hygienists' Association, Sacramento, CA, May 26.
63.
1976 Goldman, M.
A prospective on nuclear energy.
Sigma Xi, University of California, Davis, CA, flovember 18.
64.
1976 Goldman, M.
Radiation risks.
Testimony for fluclear Regulatory Commission, Diablo Canyon, San Luis Obispo, CA, December 13.
65.
1977 Goldman, M.
flaturally occurring radioactivity.
U. S. fluclear Regulatory Commission, Atlanta, GA, February 3.
66.
1977 Goldman, it.
Internal emitters and carcinogenesis.
Refresher Course, Radiation Research Society, San Juan, Puerto Rico, May 7-14.
67.
1977 Goldman, M.
Application of anim.1 experimentation to the evaluation of radiation risk.
tiorthern California Chapter, Health Physics Society, Palo Alto, CA, May 18.
68.
1977 Goldman, M. and S. S. Yaniv.
Low level radiation risks.
Testimony for fluclear Regulatory Commission, Tulsa, OK, August 24.
20 o..
69.
1977 Goldman, M. and O. G. Raabe.
An estimate of early mortality and morbidity following acute inhalation of plutonium.
1977 Winter Meeting of the American Nuclear Society, San Francisco, CA, November 29.
70.
1978 ~Goldman, M.
Radiation risk assessment fr;m high-LET to low-dose rates.
Donner Laboratory Seminar, Lawreace Berkeley Laboratory, Berkeley, CA, April 3.
71.
1978 Goldman, M.
Metabolic constraints on the radiologic hazard from 129-1 (presented for S. A. Book).
American Industrial Hygiene Conference, Los Angeles, CA, May 7-12.
72.
1978 Goldman, M.
Risks from low level radiation.
Conference on Environmental Regulation, Atomic Industrial Forum, Monterey, CA, June 11.
73.
1978 Goldman, M.
Coal and its biologic hazards.
Educational Hearing, California Energy Commission, Solano, CA, June 28.
74.
1978 Goldman, M.
Extrapolation of experimental data from animals to people.
Advisory Workshop on Carcinogenesis Effects of Coal Conversion, Pacific Grove, CA, September 26.
75.
1979 Goldman, M.
What happened at 3-mile island? How safe are atomic power plants? Dixon Masonic Lodge, Dixon, CA, May 3.
76.
1979 Goldman, M.
Effects of radiation in humans.
50/50 Club.
Sacramento, CA, May 29.
77.
1979 Goldman, M.
Radiation risk assessment - the scientific approach.
Stanford University, Palo Alto, CA, May 31.
73.
1979 Goldman, M.
Radiation risk assessment.
Pacific Gas and Electric Company, Diablo Canyon, CA, June 29.
79.
1979 Goldman, M.
Radiation risks in Rancho Seco Trespass Case.
Testimony for Sacramento County District Attorney, Elk Grove, CA, July 1979.
80.
1979 Goldman, M.
Radiation and you.
Woodland Rotary Club, Woodland, CA, July 31.
81.
1979 Goldman, M.
Forum on health hazards of nuclear power.
Ventura-Santa Barbara Health Systems Agency, Ventura, CA, September 5.
l 82.
1979 Goldman. M.
Nuclear power discussion.
Mike Douglas TV show, Los l
Angeles, CA, October 4.
83.
1979 Goldman, M.
Effects of radiation on people and the environment.
University Extension Class, University of California, Davis, CA, October 16.
i I
21
- 84. 1979 Goldman, M.
Radiation risk assessment.
Industrial Claims Association Meeting, San Francisco, CA, October 27.
- 85. 1979 Goldman, M.
Low level radiation.
Conference on Moving Ahead with Nuclear Power, Atomic Industrial Forum, San Francisco, CA, November
'14.
86.
1979 Goldman, M.
Radiation health effects and regulatory limits.
American Institute of Chemical Engineers Meeting, San Francisco, CA, November 29.
- 87. 1980 Goldman, M.
t'uclear energy.
1980 Junior League Meeting, February 4.
- 88. 1980 Goldman, M.
Radiation risks - facts and fancies. Winters Rotary Club, Winters, CA, July 23.
- 89. 1980 Goldman, M.
Current energy-related health issues.
California Association of Toxicologists Quarterly Meeting, Sacramento, CA, August 2.
- 90. 1980 Goldman, M.
Radiobiologic research on animals applied to understanding radiation risks.
Seminar to Junior Veterinary Students.
Cornell University, Ithaca, New York, October 6.
91.
1982 Goldman, M.
Early and latent off-site consequences from accidental reactor releases: A radiation risk model. Workshop on Technical Factors Relating Impacts from Reactor Releases to Emergency Planning. Marriott Hotel, Bethesda, Maryland, January 12,13, 1982.
l 1
i l
l l
1
--